Tom Powles says KIM1 may be a useful biomarker in papillary renal cancer as well as clear cell, with higher baseline levels in papillary disease and dynamic changes with effective therapy.
It looks like KIM1 might be a good biomarker in papillary renal cancer as well as clear cell.
Baseline level seem higher in papillary than clear cell
dynamic changes occur with effective therapy.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare